capsaicin · Averitas · NDA 022395
Qutenza
Earliest generic entry, as listed
26 Mar 2030
Blocked by patent: US 8821920.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8821920 | product | 26 Mar 2030 |
| US 9226903 | product | 15 Dec 2028 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022395 · 001 · RLD | patch, topical | 8% | 26 Mar 2030 |